Cephalosporin Drugs Market by Generation, Type, Route of Drug Administration and Application- Global Industry Analysis and Forecast to 2023

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Rising prevalence of chronic diseases

3.2.2.  Restraints

3.2.2.1.    Side effects related with the medicines

3.2.3.  Opportunities

3.2.3.1.    Emerging Countries to Offer Lucrative Growth Opportunities

4.       Cephalosporin Drugs Market , By Generation

4.1.       Introduction

4.2.       Global Cephalosporin Drugs Sales, Revenue and Market Share By Generation (2017-2017)

4.2.1.  Global Cephalosporin Drugs Sales and Sales Share By Generation (2017-2017)

4.2.2.  Global Cephalosporin Drugs Revenue and Revenue Share By Generation (2017-2017)

4.3.       Cephalosporin Drugs Market   Assessment and Forecast, By Generation, 2017-2023

4.4.       First-generation Cephalosporin

4.4.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.5.       Second-generation Cephalosporin

4.5.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.6.       Third-generation Cephalosporin

4.6.1.   Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.7.       Fourth-generation Cephalosporin

4.7.1.   Market Assessment and Forecast, By Region, 2017-2023 ($Million)

4.8.       Fifth-generation Cephalosporin

4.8.1.   Market Assessment and Forecast, By Region, 2017-2023 ($Million)

5.       Cephalosporin Drugs Market , By Type

5.1.       Introduction

5.2.       Global Cephalosporin Drugs Sales, Revenue and Market Share By Type (2017-2017)

5.2.1.  Global Cephalosporin Drugs Sales and Sales Share By Type (2017-2017)

5.2.2.  Global Cephalosporin Drugs Revenue and Revenue Share By Type (2017-2017)

5.3.       Cephalosporin Drugs Market   Assessment and Forecast, By Type 2017-2023

5.4.       Generics

5.4.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

5.5.       Branded

5.5.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

6.       Cephalosporin Drugs Market , By Route of Drug Administration

6.1.       Introduction

6.2.       Global Cephalosporin Drugs Sales, Revenue and Market Share By Route of Drug Administration (2017-2017)

6.2.1.  Global Cephalosporin Drugs Sales and Sales Share By Route of Drug Administration (2017-2017)

6.2.2.  Global Cephalosporin Drugs Revenue and Revenue Share By Route of Drug Administration (2017-2017)

6.3.       Cephalosporin Drugs Market   Assessment and Forecast, By Route of Drug Administration 2017-2023 ($Million)

6.4.       Injection

6.4.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

6.5.       Oral

6.5.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

7.       Cephalosporin Drugs Market , By Application

7.1.       Introduction

7.2.       Global Cephalosporin Drugs Sales, Revenue and Market Share By Application (2017-2017)

7.2.1.  Global Cephalosporin Drugs Sales and Sales Share By Application (2017-2017)

7.2.2.  Global Cephalosporin Drugs Revenue and Revenue Share By Application (2017-2017)

7.3.       Cephalosporin Drugs Market   Assessment and Forecast, By Application, 2017-2023 ($Million)

7.4.       Ear Infection

7.4.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

7.5.       Urinary Tract Infection

7.5.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

7.6.       Respiratory Tract Infection

7.6.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

7.7.       Skin Infection

7.7.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

7.8.       Sexually Transmitted Infection

7.8.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

7.9.       Others

7.9.1.  Market Assessment and Forecast, By Region, 2017-2023 ($Million)

8.       Cephalosporin Drugs Market , By Region

8.1.       Introduction

8.2.       Cephalosporin Drugs Market   Assessment and Forecast, By Region, 2017-2023 ($Million)

8.3.       Global Cephalosporin Drugs Sales, Revenue and Market Share by Regions

8.3.1.  Global Cephalosporin Drugs Sales by Regions (2017-2017)

8.3.2.  Global Cephalosporin Drugs Revenue by Regions (2017-2017)

8.4.       North America

8.4.1.  North America Cephalosporin Drugs Sales and Growth Rate (2017-2017)

8.4.2.  Market Assessment and Forecast, By Country, 2017-2023 ($Million)

8.4.3.  Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.4.4.  Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.4.5.  Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.4.6.  Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.4.7.  U.S.

8.4.7.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.4.7.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.4.7.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.4.7.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.4.8.  Canada

8.4.8.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.4.8.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.4.8.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.4.8.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.4.9.  Mexico

8.4.9.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.4.9.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.4.9.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.4.9.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.5.       Europe

8.5.1.  Europe Cephalosporin Drugs Sales and Growth Rate (2017-2017)

8.5.2.  Market Assessment and Forecast, By Country, 2017-2023 ($Million)

8.5.3.  Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.5.4.  Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.5.5.  Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.5.6.  Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.5.7.  Germany

8.5.7.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.5.7.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.5.7.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.5.7.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.5.8.  France

8.5.8.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.5.8.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.5.8.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.5.8.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.5.9.  UK

8.5.9.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.5.9.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.5.9.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.5.9.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.5.10.      Italy

8.5.10.1. Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.5.10.2. Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.5.10.3. Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.5.10.4. Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.5.11.      Spain

8.5.11.1. Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.5.11.2. Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.5.11.3. Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.5.11.4. Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.5.12.      Rest of Europe

8.5.12.1. Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.5.12.2. Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.5.12.3. Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.5.12.4. Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.6.       Asia-Pacific

8.6.1.  Asia-Pacific Cephalosporin Drugs Sales and Growth Rate (2017-2017)

8.6.2.  Market Assessment and Forecast, By Country, 2017-2023 ($Million)

8.6.3.  Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.6.4.  Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.6.5.  Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.6.6.  Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.6.7.  Japan

8.6.7.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.6.7.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.6.7.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.6.7.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.6.8.  China

8.6.8.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.6.8.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.6.8.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.6.8.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.7.       Australia

8.7.1.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.7.1.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.7.1.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.7.1.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.7.2.  India

8.7.2.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.7.2.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.7.2.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.7.2.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.7.3.  South Korea

8.7.3.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.7.3.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.7.3.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.7.3.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.7.4.  Rest of Asia-Pacific

8.7.4.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.7.4.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.7.4.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.7.4.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.8.       Rest of the World

8.8.1.  Market Assessment and Forecast, By Country, 2017-2023 ($Million)

8.8.2.  Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.8.3.  Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.8.4.  Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.8.5.  Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.8.6.  Brazil

8.8.6.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.8.6.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.8.6.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.8.6.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.8.7.  Turkey

8.8.7.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.8.7.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.8.7.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.8.7.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.8.8.  Saudi Arabia

8.8.8.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.8.8.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.8.8.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.8.8.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.8.9.  South Africa

8.8.9.1.    Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.8.9.2.    Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.8.9.3.    Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.8.9.4.    Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.8.10.      United Arab Emirates

8.8.10.1. Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.8.10.2. Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.8.10.3. Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.8.10.4. Market Assessment and Forecast, By Application, 2017-2023 ($Million)

8.8.11.      Others

8.8.11.1. Market Assessment and Forecast, By Generation, 2017-2023 ($Million)

8.8.11.2. Market Assessment and Forecast, By Type, 2017-2023 ($Million)

8.8.11.3. Market Assessment and Forecast, By Route of Drug Administration, 2017-2023 ($Million)

8.8.11.4. Market Assessment and Forecast, By Application, 2017-2023 ($Million)

9.       Company Profiles

9.1.       Eli Lilly and Company

9.1.1.  Business Overview

9.1.2.  Product Portfolio

9.1.3.  Strategic Developments

9.1.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.2.       Lupin Limited

9.2.1.  Business Overview

9.2.2.  Product Portfolio

9.2.3.  Strategic Developments

9.2.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.3.       Sanofi

9.3.1.  Business Overview

9.3.2.  Product Portfolio

9.3.3.  Strategic Developments

9.3.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.4.       Allergan

9.4.1.  Business Overview

9.4.2.  Product Portfolio

9.4.3.  Strategic Developments

9.4.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.5.       GlaxoSmithKline

9.5.1.  Business Overview

9.5.2.  Product Portfolio

9.5.3.  Strategic Developments

9.5.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.6.       Merck & Co

9.6.1.  Business Overview

9.6.2.  Product Portfolio

9.6.3.  Strategic Developments

9.6.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.7.       Pfizer

9.7.1.  Business Overview

9.7.2.  Product Portfolio

9.7.3.  Strategic Developments

9.7.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.8.       Teva Pharmaceutical Industries

9.8.1.  Business Overview

9.8.2.  Product Portfolio

9.8.3.  Strategic Developments

9.8.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.9.       Roche Holding AG

9.9.1.  Business Overview

9.9.2.  Product Portfolio

9.9.3.  Strategic Developments

9.9.4.  Cephalosporin Drugs Sales, Revenue and Market Share

9.10.    Bristol-Myers Squibb

9.10.1.       Business Overview

9.10.2.      Product Portfolio

9.10.3.      Strategic Developments

9.10.4.      Cephalosporin Drugs Sales, Revenue and Market Share

10.   Global Cephalosporin Drugs Market  Competition, by Manufacturer

10.1.    Global Cephalosporin Drugs Sales and Market Share by Manufacturer (2017-2017)

10.2.    Global Cephalosporin Drugs Revenue and Market Share by Manufacturer (2017-2017)

10.3.    Top 5 Cephalosporin Drugs Manufacturer Market Share

10.4.    Market Competition Trend

---

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Cephalosporin Drugs Market.

---

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country